2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pleural Diseases Market?

The rising occurrence of infectious diseases is anticipated to propel the pleural diseases market growth in the future. Infectious diseases are conditions brought on by destructive microorganisms such as bacteria, viruses, fungi, or parasites. Variations in human behavior due to environmental changes and advancements in global travel contribute to the increasing occurrence of these diseases. Diseases like bacterial pneumonia, tuberculosis, or viral infections can result in pleural disease by instigating inflammation, infection, or fluid buildup in the pleural cavity. For example, in January 2023, as per the National Library of Medicine, a US-based medical research and information library, infectious diseases are responsible for more than 52 million deaths yearly, thereby jeopardizing half of the global population. Moreover, each year, around 14 million children who are below the age of five die, and about 70% of these deaths are attributable to preventable diseases through vaccination. Thus, the rising occurrence of infectious diseases is stimulating the growth of the pleural diseases market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What is the Predicted Annual Growth Rate of thePleural Diseases Market Impact Industry Trends by 2034?

The market size for pleural diseases has seen significant growth in the past few years. Expected to rise from $4.86 billion in 2024 to $5.23 billion in 2025, the market will exhibit a compound annual growth rate (CAGR) of 7.6%. This growth trajectory during the historical period can be credited to factors such as increasing incidence of pleural effusion, heightened awareness of pleural diseases, a greater emphasis on early diagnosis, an escalation in the number of healthcare facilities, and an increase in clinical trials related to pleural diseases.

Expectations are high for substantial growth in the pleural diseases market in the upcoming years, with projections predicting it will reach $6.94 billion in 2029, expanding at a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this expected growth during the forecast period include increasing instances of pleural diseases, a growing aging populace, a rise in occupational hazards, an increased number of clinical trials, and a growth in diagnostic centers. Key trends projected for the forecasting period involve progress in diagnostics and diagnostic tools, preference for minimally invasive procedures, improved drug development, and the increased adoption of telemedicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

What Are the Key Market Innovations in thePleural Diseases Market Over the Coming Years?

Leading firms in the pleural diseases market are dedicating resources to the development of new treatment alternatives, including the creation of ready-to-use injectable treatments, to enhance patient convenience, lessen preparation time, and decrease dosing mistakes. These ready-to-use injectable treatments are pre-formulated and pre-diluted medications which do not need any further mixing or reconstitution before being administered, thereby ensuring accuracy, convenience, and a shorter preparation time. For example, Amneal Pharmaceuticals, an American pharmaceutical firm, introduced PEMRYDI RTU in April 2024, becoming the first company to launch a ready-to-use version of pemetrexed for injection. This has benefited patients with pleural diseases by providing a hassle-free, ready-for-use treatment that removes the necessity for further dilution or reconstitution, cuts down preparation time, lessens the likelihood of dosage errors, and enhances access to efficient treatment for disorders like malignant pleural mesothelioma.

Who Are the Top Companies Driving Innovation and Growth in thePleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Key Market Segments Comprise the Pleural Diseases Market and Drive Its Revenue Growth?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Which Regions Are Emerging as Leaders in the Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Pleural Diseases Market 2025, By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: